Read the latest news about the participation of researchers from the Barcelonaβeta Brain Research Center (BBRC) in congresses and events about Alzheimer's research.
The Barcelona Alzheimer’s HUB, supported by the Pasqual Maragall Foundation and the Barcelonaβeta Brain Research Center, held the second session of its scientific series at its headquarters, focusing on the study of fluid biomarkers.
BBRC researchers contributed to the AD/PD 2026 International Conference with four oral presentations and two posters.
During his presentation, he highlighted biomarker advances, from biology to their application in patients and clinical settings.
Our researchers will present 7 talks and 22 scientific posters during the 5 days of the congress
BBRC researchers share key advances in Alzheimer's and neurosciences in the framework of the AD/PD 2025.
The event programme included six scientific posters on the centre's research.
During the meeting, the teams will disseminate the news of their research in the international scientific community.
According to the data presented, and simultaneously published in JAMA, the treatment with donanemab will significantly reduce the levels of amyloid plaque.
During the meeting, the teams will disseminate their research findings to the international scientific community.